Tisch MS Research Center of New York (Tisch MSRCNY) will hold its' 20th Annual MS Patient Education Symposium on Sunday, October 22nd at the New York Hilton in Midtown. The doors open at 8:30am and the program will be from 9:30am to 1:00pm.

To register please visit:

We are... more


This letter is to inform you that as of August 31, 2017, Dr. Andrew Sylvester will no longer be a provider at the International Multiple Sclerosis Management Practice. Dr. Sylvester and the IMSMP are currently working to ensure that you continue to receive the same level of care, without disruption.

You, as the patient, have two options going forward:

1. Dr. Sylvester will become the new Medical Director of the Multiple Sclerosis Comprehensive Care Center at St. Barnabas Health... more


We are thrilled to announce, Dr. Saud A. Sadiq is a, New York Magazine, Best Doctor in the field of Neurology for 2017. Of the 40 neurologists selected for this prestigious recognition, Dr. Saud A. Sadiq is the only physician listed who specializes in multiple sclerosis.

To view Dr. Saud A. Sadiq's full bio, Click Here.

To view New York Magazine's Best Doctor's list,... more


What's the Latest in the Pipeline for MS Drugs that Might Help?

"Whether you’ve just been diagnosed with multiple sclerosis or you’ve been dealing with your symptoms for years, it’s in your best interest to keep on top of the latest advances in medications. The good news is there are plenty of drugs being tested, and hopefully many will get through the regulatory pipeline to help patients cope with their MS. . ."

... more


Ocrelizumab (OCREVUS™), an anti-B cell therapy has been approved by the FDA as of March 28th 2017, for the treatment of Relapsing-remitting multiple sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS). This treatment is highly effective for RRMS, based on the data from the Phase III clinical studies. It is also the first drug approved for use in PPMS. At IMSMP/TISCH we have used Rituximab, a similar anti-B cell treatment, for the past 16 years with great success. It is because... more


We are looking for patient stories to post on social media throughout the month of March and all year round! Please share with us what keeps you motivated, how you achieve your goals and triumphs along the way. The IMSMP is inspired every day by our patients. Help us share that inspiration! To be a part of these special posts, please email: more


Congratulations to Dr. Saud A. Sadiq, Dr. Andrew Sylvester and Dr. Armistead D. Williams who have all been named a 2017 Top Doctor in the field of Neurology for the New York Metro Area by Castle Connolly. In addition, Dr. Sadiq has been named a 2017 America's Top Doctor in the field of Neurology by Castle Connolly.

The mission of Castle Connolly Medical Ltd. is to help consumers find the best healthcare. To this end, they publish a variety of books including the "Top Doctors" series,... more


Great article and great way to start the new year. Time for a change in Connecticut for the access symbol. Read the full article here:


Learn more about Phase II of the Tisch MSRCNY Stem Cell Trial for MS and how it differs from HSCT. CLICK HERE to watch this informative interview!


The IMSMP will be closed on Friday, December 30th, 2016 and Monday, January 2nd, 2017. A neurologist will be available for any MS related emergencies by calling (212) 265-8070. The Center will re-open on Tuesday, January 3rd, 2017. We wish everyone a safe holiday weekend and a wonderful year to come, filled with health and happiness!



Because you deserve only the best in MS healthcare. Experience the difference.

Newsletter Sign Up

Join our mailing list today!  Receive the latest information and updates happening in MS research, treatment and care including, Healing MS, the IMSMP newsletter.

* We don’t share your information with anyone.